Regeneron (REGN) Tops Q2 EPS by 104c, Sales Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Regeneron Pharma (REGN) PT Raised to $472 at Goldman Sachs
August 4, 2017 7:00 AM EDTGoldman Sachs raised its price target on Regeneron Pharma (NASDAQ: REGN) to $472.00 (from $469.00) while maintaining a Neutral rating.
... MoreRegeneron Pharma (REGN) PT Raised to $455 at JPMorgan
August 4, 2017 6:58 AM EDTJPMorgan raised its price target on Regeneron Pharma (NASDAQ: REGN) to $455.00 (from $427.00) while maintaining a Neutral rating.
... MoreRegeneron Pharma (REGN) PT Raised to $580 at Leerink Partners
August 4, 2017 6:55 AM EDTLeerink Partners raised its price target on Regeneron Pharma (NASDAQ: REGN) to $580.00 (from $573.00) while maintaining a Outperform rating.
... MoreRegeneron Pharma (REGN) PT Raised to $575 at Citi
August 4, 2017 6:53 AM EDTCiti raised its price target on Regeneron Pharma (NASDAQ: REGN) to $575.00 (from $555.00) while maintaining a Buy rating.
... More